COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01622439
Brief Title: Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell Lymphoma (VALFRID)

First Submitted : June 12, 2012
First Submitted that Met QC Criteria : June 18, 2012
First Posted : June 19, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : March 9, 2018
Last Update Posted : March 12, 2018